Skip to main content

Advertisement

Table 2 Frequency and duration of reported side effects among among mothers of infants of group A (N = 45) and group B (N = 45) of an ITN trial conducted in Burkina Faso

From: Safety of insecticide-treated mosquito nets for infants and their mothers: randomized controlled community trial in Burkina Faso

Reported side effects Week 1 Week 2–4 Week 1–18
Frequencya RR (95 % CI)b P-valueb Duration of symptom (Days) P-valuec Frequency RR (95 % CI) P-value Duration of symptom (Days) P-value Frequency RR (95 % CI) P-value Duration of symptom (Days) P-value
A B A B A B    A B A B
Headache/diziness 11 2 6.96 (1.35–67.43) 0.01 27 5 0.55 7 5 1.48 (0.37–6.40) 0.76 44 13 0.22 15 9 2.00 (0.70–5.94) 0.23 79 22 0.43
Rhinitis 5 3 1.75 (0.31–11.94) 0.71 10 14 0.39 5 7 0.67 (0.16–2.74) 0.76 103 143 0.94 12 7 1.97 (0.62–6.61) 0.30 71 49 0.68
Skin Eruption 4 2 2.09 (0.28–24.17) 0.68 19 7 0.51 6 2 3.31 (0.54–34.94) 0.27 43 2 0.11 7 3 2.58 (0.54–16.38) 0.31 77 10 0.15
Pruritus 2 2 1.00 (0.07–14.38) 1.00 7 7 1.00 2 0 0.49 12 0 4 2 2.09 (0.28–24.17) 0.68 24 8 0.52
Parestheia 2 2 1.00 (0.07–14.38) 1.00 3 2 1.00 2 0 0.49 12 0 2 3 0.65 (0.05–6.01) 1.00 15 3 0.22
Cough 1 0 1.00 1 0 5 1 5.50 (0.57–265.92) 0.20 30 5 1.00 6 2 3.31 (0.54–34.94) 0.27 37 6 0.75
Conjunctivits 2 0 0.49 2 0 2 1 2.05 (0.10–123.44) 1.00 9 1 0.60 3 3 1.00 (0.13–7.90) 1.00 10 4 0.24
Others 8 5 1.73 (0.45–7.31) 0.55 28 12 0.43 11 9 1.29 (0.43–4.01) 0.80 64 42 0.15 14 11 1.40 (0.50–3.95) 0.64 72 53 0.77
  1. Group A Infants protected from birth onwards
  2. Group B Infants protected from month six onwards
  3. RR risk ratio, CI confidence interval
  4. aNumber of mothers with at least one episode of respective side effects
  5. bCalculated with Fisher’s tests and RR is based on episode duration
  6. cTotal number of days (sum) of observed symptom per group